PURPOSE: Fear of cancer recurrence (FCR) is common and associated with younger age. This study aimed to explore the prevalence and correlates of FCR amongst younger survivors of early breast cancer. SUBJECTS: A total of 218 women aged 18-45 were diagnosed with stage 0-2 breast cancer at least 1 year earlier. METHODS: The participants completed a web-based survey including a validated measure of FCR and items exploring medical surveillance practices and health care use. RESULTS: A total of 70% of participants reported clinical levels of FCR. Higher FCR was associated with higher frequency of unscheduled visits to the GP, higher frequency of breast self-examination and other forms of self-examination for cancer, not having mammograms or ultrasounds or other forms of cancer screening in the past year, more complementary therapy use and the use of counselling and support groups. CONCLUSIONS: Young women with breast cancer are particularly vulnerable to FCR. The present study provides preliminary evidence that FCR is associated with higher health costs and lower surveillance rates which may compromise health outcomes. Routine screening for FCR in follow-up care is recommended.
PURPOSE: Fear of cancer recurrence (FCR) is common and associated with younger age. This study aimed to explore the prevalence and correlates of FCR amongst younger survivors of early breast cancer. SUBJECTS: A total of 218 women aged 18-45 were diagnosed with stage 0-2 breast cancer at least 1 year earlier. METHODS: The participants completed a web-based survey including a validated measure of FCR and items exploring medical surveillance practices and health care use. RESULTS: A total of 70% of participants reported clinical levels of FCR. Higher FCR was associated with higher frequency of unscheduled visits to the GP, higher frequency of breast self-examination and other forms of self-examination for cancer, not having mammograms or ultrasounds or other forms of cancer screening in the past year, more complementary therapy use and the use of counselling and support groups. CONCLUSIONS: Young women with breast cancer are particularly vulnerable to FCR. The present study provides preliminary evidence that FCR is associated with higher health costs and lower surveillance rates which may compromise health outcomes. Routine screening for FCR in follow-up care is recommended.
Authors: James L Khatcheressian; Antonio C Wolff; Thomas J Smith; Eva Grunfeld; Hyman B Muss; Victor G Vogel; Francine Halberg; Mark R Somerfield; Nancy E Davidson Journal: J Clin Oncol Date: 2006-10-10 Impact factor: 44.544
Authors: Sally E Dodds; Thaddeus W W Pace; Melanie L Bell; Mallorie Fiero; Lobsang Tenzin Negi; Charles L Raison; Karen L Weihs Journal: Support Care Cancer Date: 2015-08-16 Impact factor: 3.603
Authors: Amy K Otto; Emily C Soriano; Scott D Siegel; Stefanie T LoSavio; Jean-Philippe Laurenceau Journal: J Cancer Surviv Date: 2018-10-19 Impact factor: 4.442
Authors: Shelley A Johns; Patrick V Stutz; Tasneem L Talib; Andrea A Cohee; Kathleen A Beck-Coon; Linda F Brown; Laura R Wilhelm; Patrick O Monahan; Michelle L LaPradd; Victoria L Champion; Kathy D Miller; R Brian Giesler Journal: Cancer Date: 2019-09-20 Impact factor: 6.860
Authors: Louise Sharpe; J Turner; J E Fardell; B Thewes; A B Smith; J Gilchrist; J Beith; A Girgis; S Tesson; S Day; K Grunewald; P Butow Journal: J Cancer Surviv Date: 2019-07-25 Impact factor: 4.442